Behandling af centralnervesystemlymfom efter transplantation med monoklonalt antistof og ganciclovir

P.B. Hansen; G. Al-Farra

Behandling af centralnervesystemlymfom efter transplantation med monoklonalt antistof og ganciclovir

P.B. Hansen
, G. Al-Farra

1 Citationer (Scopus)

Abstract

A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion

Bidragets oversatte titel	Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	172
Udgave nummer	42
Sider (fra-til)	2907-2908
Antal sider	2
ISSN	0041-5782
Status	Udgivet - 2010

Citationsformater

@article{7bccf0dcbd274009abb2afa3643a0089,

title = "Behandling af centralnervesystemlymfom efter transplantation med monoklonalt antistof og ganciclovir",

abstract = "A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion",

author = "P.B. Hansen and G. Al-Farra",

year = "2010",

language = "Dansk",

volume = "172",

pages = "2907--2908",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "42",

}

TY - JOUR

T1 - Behandling af centralnervesystemlymfom efter transplantation med monoklonalt antistof og ganciclovir

AU - Hansen, P.B.

AU - Al-Farra, G.

PY - 2010

Y1 - 2010

N2 - A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion

AB - A 35-year-old female was diagnosed with a primary central nervous system posttransplant Epstein-Barr-virus-associated lymphoproliferative disorder three years after a renal transplantation. The histological diagnosis of the brain tumour was a diffuse large B-cell lymphoma. The patient had had diabetes mellitus for 28 years and was treated with four weekly doses of the monoclonal antibody rituximab, the antiviral drug ganciclovir and high-dose prednisolone, and the immune suppression was reduced. After four weeks of treatment, a control magnetic resonance image showed complete regression of the central nervous system lesion

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 2907

EP - 2908

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 42

ER -